Hosted on MSN1mon
Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements
and community testing, which increased 38%. Adaptive announced a strategic partnership with NeoGenomics to cross-promote clonoSEQ and Neo’s COMPASS and CHART services, aiming to expand its ...
Hosted on MSN4mon
What does "adaptive test format" mean in the context of the NMAT exam?
N MAT is a high-quality, secure "Computer Adaptive Test" in which a candidate's ability is estimated successively based on the responses to the questions administered, which are tailored to the ...
Daily Sabah3d
AI tool in Türkiye personalizes education for high school students
The Ministry of National Education (MEB) has launched the AI-supported personalized learning platform MEBI to enhance ...
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...